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osting by EAbstract Chromatographic fractionation of the alcoholic extract of the dried fronds of Adiantum
capillus-veneris L. (Adiantaceae) yielded seven compounds: four triterpenoidal compounds belonging
to adiantane and ﬁlicane groups were isolated from the hexane fraction and identiﬁed as isoadian-
tone (1); isoadiantol-B (2); 3-methoxy-4-hydroxyﬁlicane (3) and 3,4-dihydroxyﬁlicane (4) and three
ﬂavonoids were isolated from the ethyl acetate fraction and identiﬁed as: quercetin (5), quercetin-3-
O-glucoside (6) and quercetin-3-O-rutinoside (rutin) (7). The identiﬁcation of the isolated com-
pounds has been established through their physical, chemical and spectroscopic methods including
IR, 1H NMR, 13C NMR, HSQC, HMBC, NOESY and MS. Biological studies of the total alcoholic
extract, hexane fraction and some of the isolated compounds showed an anti-inﬂammatory activity
while the hypoglycemic study of the total alcoholic extract showed a signiﬁcant activity.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Adiantum capillus-veneris belonging to the Adiantaceae family
is one of the most common and widely distributed species88 2411336; mobile: +20
tmail.com (Z.Z. Ibraheim).
y. Production and hosting by
Saud University.
lsevier(Singh et al., 2008). Ethnomedicinally, the genus has been used
as tonic and diuretic; in treatment of cold, fever, cough and
bronchial disorders, as stimulant, emollient, purgative, demul-
cent, general tonic and hair tonic, in addition to skin diseases,
tumors of spleen, liver and other viscera (Singh et al., 2008), in
treatment of jaundice and hepatitis (Abbasi et al., 2009) and
many other uses (Abbasi et al., 2010; Ahmad et al., 2008;
Al-Qura’n, 2009; Camejo-Rodrigues et al., 2003; Dastagir,
2001; De Natale and Pollio, 2007; Ghorbani, 2005; Guarrera
et al., 2008; Guarrera, 2005; Hamayun et al., 2006; Hammond
et al., 1998; Inam et al., 2000; McGaw et al., 2008; Shinozaki
et al., 2008; Shinwari and Khan, 2000; Uncini Manganelli
et al., 2001). Concerning the phytoconstituents, the literature
revealed the presence of ﬂavonoids (Imperato, 1982a,b; Pour-
morad et al., 2006), sulphate esters of hydroxycinnamic acid–
sugars (Imperato, 1982c,d), different classes of triterpenoids
(Abdel-Halim et al., 2002; Berti et al., 1963, 1969; Imperato,
1982c; Jankowski et al., 2004; Nakane et al., 1999, 2002;
66 Z.Z. Ibraheim et al.Shinozaki et al., 2008; Zaman et al., 1966), sterols (Guarrera
et al., 2008; Marino et al., 1989), quinic and shikimic acids
in addition to other constituents (Abbasi et al., 2010; Chiang
and Lin, 1979; El-Tantawy et al., 1994; El-Tantawy, 1989;
Imperato, 1982c; Mahran et al., 1994; McGaw et al., 2008;
Victor et al., 2003). The anti-microbial (Abdel-Halim et al.,
2002; Besharat et al., 2008; Guha et al., 2005; Hammond
et al., 1998; Kumar and Aushik, 1999; Kumar et al., 2003;
Mahmoud et al., 1989; Mahran et al., 1990; Singh et al.,
2008; Victor et al., 2003), antioxidant, anti-implantation, anti-
diabetic in addition to other effects of this species (El-Sheimy
et al., 1995; El-Tantawy et al., 1994; Gupta et al., 2010; Kumar
et al., 2003; Kumar, 2009; Murthy et al., 1984; Pourmorad
et al., 2006) were previously reported. The present study deals
with the isolation and identiﬁcation of the main constituents of
the hexane and ethyl acetate fractions in addition to the study
of the anti-inﬂammatory and hypoglycemic activities to verify
these effects using experimental animals.2. Materials and methods
2.1. Plant material
The dried fronds of A. capillus-veneris were collected from the
local market of Assiut Governorate, Assiut, Egypt, April 2008.
The identity of the plant was conﬁrmed by Prof. Dr. Abd El-
Aziz Fayed, Prof. of Taxonomy, Faculty of Science, Assiut
University, Assiut, Egypt. A voucher sample (No. 20103)
was kept in the Herbarium of Faculty of Pharmacy, Assiut
University, Assiut, Egypt.
2.2. General experimental procedure
Melting points were uncorrected and determined using Stuart
SMP3 digital melting point apparatus (UK). 1H NMR
(400 MHz) and 13C NMR (100 MHz) spectra were measured
using a Varian Unity INOVA spectrometer using TMS as an
internal standard. UV spectra were measured using Evolution
300 UV–VIS spectrophotometer (England). IR spectra were
recorded in KBr using Shimadzu IR-470 spectrometer (Japan).
Mass spectra were carried out using JEOL JMS600 spectrom-
eter. Column chromatography was performed on Kieselgel 60
(60–230 mesh, Merck) and TLC was carried out with silica gel
60 precoated plates F-254 (Merck) and Whatman sheets Nos. 1
and 3 (England) for paper chromatography. One touch appa-
ratus and its strips (Lifescan, Johnson and Johnson Inc.) for
blood glucose level determination.
2.3. Extraction and isolation
The dried powdered fronds of A. capillus-veneris (800 g) were
extracted with alcohol (3 l · 3) by maceration and percolation.
The combined alcoholic extract was concentrated under re-
duced pressure using rotary evaporator till dryness (220 g). Part
of the dried residue (150 g) was mixed with distilled water
(500 ml) and subjected to fractionation between hexane
(700 ml · 4), chloroform (500 ml · 3), ethyl acetate (500 ml ·
4) and ﬁnally n-butanol (500 ml · 3). Each fraction was dried
under reduced pressure; the solvent-free residue in each case
was weighed to give dry weight of hexane (70 g), chloroform
(12 g), ethyl acetate (22 g) and n-butanol (30 g) extracts.Twenty grams of the hexane fraction were subjected to sil-
ica gel CC. Elution was started with hexane then hexane–ethyl
acetate in gradient elution manner; fractions (200 ml, each)
were collected and monitored with silica gel TLC using hex-
ane–ethyl acetate in different ratios, similar fractions were
pooled together giving ﬁve groups (I–V). Group (I) eluted with
hexane only contained gummy residue which showed many
inseparable spots; group (II) which eluted with hexane–ethyl
acetate (95:5) and group (III) which eluted with hexane–ethyl
acetate (90:10) were subjected to repeated crystallization to af-
ford compounds 1 (200 mg) and 2 (90 mg), respectively. Group
(IV) eluted with hexane–ethyl acetate (80:20) was subjected to
repeated column chromatography over silica gel column and
eluted with benzene–ethyl acetate (85:15 to 80:20) that affor-
ded two sub-groups (IV-a and IV-b) which upon re-crystalliza-
tion afforded compounds 3 (50 mg) and 4 (63 mg),
respectively. Group (V) now is still under investigation.
Ten grams of the dried ethyl acetate fraction was chromato-
graphed over silica gel CC and eluted with chloroform–meth-
anol gradiently where four fractions (F-1–F-4) were obtained.
Fraction (F-2) eluted with chloroform–methanol (9:1) upon
preparative silica gel TLC using chloroform–methanol (9:1),
afforded compound 5 (32 mg). Fractions (F-3 and F-4) ob-
tained by chloroform–methanol (85:15 to 70:30) were sub-
jected to preparative paper chromatography using Whatman
sheets No. 3 and butanol–acetic acid–water (4:1:5, v/v/v, upper
layer) as a developer. They afforded compounds 6 (26 mg) and
7 (42 mg), respectively.
2.4. Acid hydrolysis
Few milligrams of each of compounds 6 and 7 were separately
dissolved in 5 ml MeOH to which an equal volume of 10% sul-
furic acid was added. The mixture was reﬂuxed on a boiling
water bath for 3 h, then cooled. The hydrolyzate was shaken
with ethyl acetate (3 · 50 ml). The combined extract was dis-
tilled off and the aglycone was subjected to TLC using
CHCl3–MeOH (85:15) as solvent system. The acidic mother li-
quor containing the sugar moiety(s) was neutralized with bar-
ium carbonate, concentrated and separately spotted alongside
authentic sugars on Whatman No. 1 sheets using n-butanol–
acetic acid–water (4:1:2, v/v/v) as a solvent system.
2.5. Animals
Adult male mice (25–30 g) and rabbits (1.2–1.5 kg) were used.
They were housed in standard environmental conditions in an
experimental animal room and fed laboratory diet ad libitum
with free access to water. Sixty-six mice were divided into 11
groups (six mice, each) and nine rabbits were used divided into
3 groups (three rabbits, each). The animals were kept for
7 days with 12 h light/dark cycle.
2.6. Anti-inﬂammatory activity
2.6.1. Formalin induced hind paw edema in mice
Fifty microliters of 3.5% formalin solution in 0.9% normal
saline was injected into the right hind paw of the mice while
the left paw was injected with the vehicle (2% PEG in 0.9%
normal saline solution) as a control. One hour after formalin
injection, the inﬂammation was measured by cutting both feet
at the level of knee joint and comparing the weight of the right
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weight was determined as follows:
I% ¼ ðWr WlÞ  100=Wl
where I%= increase in the paw weight; Wr =weight of the
right hind paw that received formalin; Wl =weight of the left
hind paw that received the vehicle.
Total alcoholic extract, hexane fraction (400 mg/kg, each)
and sodium salicylate (200 mg/kg) were solubilized in 0.9%
normal saline with the aid of 2% polyethylene glycol-400
(PEG-400) and administered orally once a day for four days
via stomach tube. PEG-400 (2% in 0.9% normal saline solu-
tion) was used as a negative control. On the fourth day, the
fractions under test and sodium salicylate were used 1 h before
formalin injection.
2.6.2. Topical anti-inﬂammatory activity
2.6.2.1. Croton oil-induced edema. Croton oil inﬂammatory
mixture was prepared by adding croton oil (250 mg) to a mix-
ture of pyridine–ether–distilled water (4:5:1, v/v/v) and kept in
the refrigerator till used.
2.6.2.2. Preparation of the tested fractions and pure compounds
for topical application. The ointment base used consists of
emulsifying wax (4.5 g), liquid parafﬁn (3.0 g) and white soft
parafﬁn (7.5 g). The hexane extract was added to the ointment
base by 10% replacement while the isolated compounds by 5%
replacement. The ear thickness was measured before and after
induction of inﬂammation by means of an Oditest caliper. The
ear inﬂammation was induced according to (Tubaro et al.,
1985), 10 ll of croton oil inﬂammatory mixture was applied
by means of an Eppendorf pipette to the inner side of the left
ear of each mouse while the right one was left untreated. The
formulated extract (2.5 mg), pure compounds (1.25 mg) and
positive control (niﬂumic acid, 1.25 mg) were applied to the
respective mice groups and their effects were evaluated. Mea-
surement of ear thickness was carried out at 2, 6, 24 and
30 h after treatment with total hexane fraction, pure com-
pounds and the positive control. The edema was expressed
as the difference between right and left ear thickness.
2.7. Hypoglycemic study
2.7.1. Assessment of hypoglycemic activity in normal healthy
mice
Fasted mice (18 h) were divided into three groups of six ani-
mals each. Group I (control group) received vehicle (2%
PEG-400), while groups II received the total alcoholic extract
at dose 400 mg/kg body weight via stomach tube. Group III
received glipizide at dose 8 mg/kg body weight as a reference
standard drug. Blood samples were withdrawn from the cav-
ernous sinus with a capillary tube and the blood glucose levels
were estimated (mg/dl) at 0.0, 30, 60, 90, 120 and 150 min
using one touch glucometer.
2.7.2. Assessment of anti-hyperglycemic activity using oral
glucose tolerance test (OGTT)
The overnight fasted rabbits were divided into three groups of
three animals each. Group I was given glucose solution (2.25 g/
kg body weight) orally using stomach tube, the total alcoholic
extract (600 mg/kg) was administered simultaneously (group
II) and 30 min before glucose loading (group III). Blood sam-ples were collected from the ear vein at zero time and after 30,
60, 120 and 240 min. after the glucose administration.
2.7.3. Determination of blood glucose level
The blood glucose level was determined by the glucose oxidase
method (Rheney and Kirk, 2000).
2.8. Chemicals
Croton oil, formalin, glipizide and sodium salicylate were ob-
tained from Sigma. Polyethylene glycol-400 (Merk, Germany),
niﬂumic acid (Archimica GmbH, Germany).
2.9. Statistical analysis
All the results were expressed as mean ± SEM. The signiﬁ-
cance in results from control group was calculated using the
Student’s t-test and a probability level lower than 0.05 was
considered as statistically signiﬁcant (Suleyman et al., 1999).
3. Results
Seven compounds were isolated from the fractionated alco-
holic extract of A. capillus-veneris. The biological activity of
the total alcoholic extract, hexane fraction and some of the iso-
lated compounds were studied.
3.1. The physical and spectral data of the isolated compounds
3.1.1. Compound 1
Needle crystals (CHCl3–MeOH). m.p.: 236–238 C. IR (KBr):
2933, 1691 cm1, EI-MS m/z (% rel. int.) 412 [M]+ (27), 397
(6), 369 (5), 191 (100). 1H and 13C NMR data: Tables 1 and 2.
3.1.2. Compound 2
Needle crystals (Et2O–MeOH). m.p.: 213–215 C. IR (KBr):
3390, 2935 cm1, EI-MS m/z (% rel. int.) 414 [M]+ (24), 399
(14), 369 (11), 207 (16), 193 (49), 191 (100), 175 (36), 149
(20). 1H and 13C NMR data: Tables 1 and 2.
3.1.3. Compound 3
Needle crystals (CHCl3). m.p.: 237–239 C. IR (KBr): 3410,
2920 cm1, EI-MS m/z (% rel. int.) 458 [M]+ (2), 341 (81),
217 (9), 205 (35), 191 (21), 149 (17), 136 (29). 1H and 13C
NMR data: Tables 1 and 2.
3.1.4. Compound 4
Needle crystals (MeOH). m.p.: 196–198 C. IR (KBr): 3465,
2955, 1373, 1033, 875 cm1, EI-MS m/z (% rel. int.) 444
[M]+ (34), 429 (66), 426 (15), 411 (17), 401 (4), 359 (14), 341
(19), 340 (56), 276 (13), 275 (24), 273 (36), 258 (16), 244 (12),
230 (14), 219 (29), 206 (19), 205 (61), 192 (23), 191 (68), 175
(22), 163 (32), 161 (26), 149 (38), 147 (21),137 (56), 136 (20),
107 (50). 1H and 13C NMR data: Tables 1 and 2.
3.1.5. Compound 5
Yellow needles (MeOH). m.p.: >300 C, 1H NMR (400 MHz,
DMSO-d6), dH 7.72 (1H, dd, J= 2.2 and 8.8 Hz, H-60), 7.55
(1H, d, J= 2.2 Hz, H-20), 6.85 (1H, d, J= 8.8 Hz, H-50),
6.44 (1H, d, J= 2.1 Hz, H-8) and 6.27 (1H, d, J= 2.1 Hz,
H-6). The UV spectral data with different ionizing and com-
plexing reagents are cited in Table 3.
Table 1 13C NMR spectral data of compounds 1–4 in CDCl3.
C Compound 1 Compound 2 Compound 3 Compound 4 C Compound 1 Compound 2 Compound 3 Compound 4
1 40.54 40.52 16.01 15.46 16 21.78 23.86 35.86 35.69
2 18.90 18.70 25.19 30.23 17 54.40 55.00 42.79 42.61
3 42.32a 42.12 86.20 76.03 18 45.21 45.05 51.96 51.60
4 33.47 33.27 76.89 76.39 19 40.27 39.71 20.13 19.75
5 56.32 56.13 42.17 41.53 20 25.73 24.30 28.65 28.34
6 18.90 18.70 34.61 34.17 21 53.99 47.46 60.30 59.95
7 33.62 33.40 17.84 17.74 22 213.00 73.01 30.99 30.61
8 42.13 41.92 49.22 48.78 23 33.47 33.27 21.64 20.33
9 50.60 50.43 37.77 37.37 24 21.80 21.59 17.73 17.28
10 37.61 37.41 52.58 51.92 25 16.07 15.85 20.78 18.01
11 21.06 20.92 36.17 35.52 26 16.90 16.75 16.13 15.95
12 24.30 22.78 28.70 28.93 27 16.92 16.75 15.85 15.58
13 48.38 48.46 39.20 38.84 28 15.16 15.21 16.31 16.21
14 42.18a 42.00 40.42 40.05 29 30.42 21.73 22.17 21.78
15 32.61 32.71 29.28 29.56 30 23.13 22.72
OMe 57.92
a Data may be interchangeable.
Table 2 1H NMR spectral data of compounds (1–4) and HMBC of compounds 3, 4 in CDCl3.
H 1 2 3 HMBC 4 HMBC
3 1.33, m
1.10, m
1.35, m
1.10, m
2.94, m C-1, C-4, C-5, OMe 3.56, dd, 7.0, J= 13.9 Hz C-1, C-4, C-5
22 – 3.61, q 1.42, m – 1.40, m –
23 0.85, s 0.82, s 1.16, s C-3, C-5 1.15, s C-3, C-5
24 0.77, s 0.71, s 0.99, s C-4, C-6, C-10 1.06, s C-4, C-6, C-10
25 0.82, s 0.79, s 0.87, s C-8, C-10, C-11 0.82, s C-8, C-10, C-11
26 0.93, s 0.93, s 0.87, s C-8, C-15 0.81, s C-8, C-15
27 0.94, s 0.95, s 0.92, s C-12, C-14, C-18 0.99, s C-12, C-14, C-18
28 0.67, s 0.66, s 0.75, s C-16, C-18, C-21 0.71, s C-16, C-18, C-21
29 2.12, s 1.14, d, J= 6.2 Hz 0.80, d, J= 6.7 Hz C-21, C-30 0.74, d, J= 6.6 Hz C-21, C-30
30 – – 0.86, d, J= 6.7 Hz C-21, C-29 0.79, d, J= 6.6 Hz C-21, C-29
OMe – – 3.26, s C-3 – –
Table 3 UV spectral data of ﬂavonoidal compounds 5–7 with different ionizing and complexing reagents.
Compounds MeOH NaOMe AlCl3 AlCl3 + HCl NaOAc NaOAc + H3BO3
5 256
266
295
370
270
297
415
254
276
299
445
267
277
299
404
264
280
297
411
259
300
392
6 253
305
357
271
327
410
273
301
330
433
273
297
353
404
274
322
383
259
379
7 259
266
299
359
272
327
410
275
303
433
271
300
364
402
271
325
393
262
298
389
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Yellow ﬁne needles (MeOH). m.p.: 207–210 C, 1H NMR
(400 MHz, DMSO-d6): dH 7.63 (1H, dd, J= 2.2 and 8.5 Hz,
H-60), 7.51 (1H, d, J= 2.2 Hz, H-20), 6.81 (1H, d,
J= 8.5 Hz, H-50), 6.38 (1H, d, J= 2.0 Hz, H-8) and 6.22
(1H, d, J= 2.0 Hz, H-6), 5.22 (1H, d, J= 7.6 Hz, H-100),
3.1–4.0 (6H, m, other-glu. protons). The UV spectral data with
different ionizing and complexing reagents are cited in Table 3.3.1.7. Compound 7
Fine yellowish needles (MeOH). m.p.: 197–199 C, 1H NMR
(400 MHz, DMSO-d6): dH 12.62 (1H, s, C-5-OH), 7.56 (1H,
dd, J= 2.1 and 8.8 Hz, H-60), 7.55 (1H, d, J= 2.1 Hz, H-
20), 6.87 (1H, d, J= 8.8 Hz, H-50), 6.40 (1H, d, J= 2.0 Hz,
H-8), 6.21 (1H, d, J= 2.0 Hz, H-6), 5.35 (1H, d, J= 7.4 Hz,
H-100-glu), 5.12 (1H, d, J= 1.9 Hz, H-1000-Rham), 1.01 (3H,
d, J= 6.1 Hz, CH3–Rh), 3.0–4.4 (10H, m, other-glu., rham.
Table 6 Anti-inﬂammatory effect of compounds 2–4 using
croton oil-induced inﬂammation.
M (lm) ± SEM
After 2 h After 6 h After 24 h After 30 h
Compound 2 53 ± 2.9 46 ± 3.1 45 ± 1.8 48 ± 3.7
Compound 3 51 ± 4.8 43 ± 2.7* 44 ± 1.9* 45 ± 3.7*
Compound 4 49 ± 2.2 46 ± 1.2* 39 ± 1.4* 36 ± 6.4*
Control 55 ± 2.8 50 ± 1.7 48 ± 1.6 56 ± 4.7
Each group contains six mice.
* P< 0.05.
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complexing reagents are cited in Table 3.
3.2. Biological activity
3.2.1. Formalin induced inﬂammation
Both of the total alcoholic extract and its hexane fraction
showed a signiﬁcant anti-inﬂammatory activity in formalin in-
duced edema. The total alcoholic extract showed a signiﬁcant
reduction (28%) compared with the positive control (sodium
salicylate). The hexane fraction showed a reduction compara-
ble with that of the positive control. The results were cited in
Table 4.
3.2.2. Croton oil-induced inﬂammation
The hexane fraction obtained from the total alcoholic extract
showed topical anti-inﬂammatory activity after 6 h and contin-
ued for 30 h. Compound 2 showed non-signiﬁcant topical anti-
inﬂammatory activity; whereas compounds 3 and 4 showed
topical anti-inﬂammatory activity after 6 h and continued for
30 h. The results are listed in Tables 5 and 6.
3.2.3. Hypoglycemic activity
3.2.3.1. Effect on normal mice. The total alcoholic extract
showed non-signiﬁcant hyperglycemia. The results are listed
in Table 7.
3.2.3.2. Effect on glucose loaded rabbits. The OGTT showed
the highest blood glucose level after 30 min. After concurrently
administered alcoholic extract at dose 600 mg/kg, a signiﬁcant
hypoglycemic effect was obtained after 30 min for group II
which continued for 4 h, while in group III the hypoglycemic
effect was continued for 2 h. The results are listed in Table 8.Table 4 Anti-inﬂammatory effects of total alcoholic extract
and hexane fraction on formalin induced edema.
Group Swelling of paws
(M± SEM)
% of inhibition
Control 2% PEG (400) 3.32 ± 0.33 –
Total alcohol extract 2.44 ± 0.26* 28
Hexane fraction 2.01 ± 0.21* 39
Sodium salicylate 1.89 ± 0.12* 41
SEM= Standard error of mean.
* P< 0.05.
Table 5 Anti-inﬂammatory effect of the total hexane fraction using
Group No. M (lm) ± SEM
After 2 h A
Group 1 (niﬂumic acid) 33.3 ± 1.2 3
Group 2 (hexane fraction) 51.4 ± 2.2 4
Group 3 (negative control) 85.6 ± 2.2 8
SEM= Standard error of mean.
* P< 0.05.4. Discussion
4.1. Identiﬁcation of the isolated compounds
The physical characters and spectral data (1H and 13C NMR)
of compounds 1 and 2 (experimental part and Tables 1 and 2)
were found to be identical to those reported for isoadiantone
and isoadiantol-B, respectively (Shiojima and Ageta, 1994;
Shiojima et al., 1993). Further conﬁrmation was carried out
by co-chromatography using authentic samples. These com-
pounds were previously isolated from the same plant (Abdel-
Halim et al., 2002) (Fig. 1).
Compound 3: Needle crystals that gave positive color with
Liebermann–Burchard’s test suggested its triterpenoidal nat-
ure. The IR spectrum showed the presence of hydroxyl group
(3410 cm1) and aliphatic C–H stretching group (2920 cm1).
The molecular formula of compound 3 was deduced to be
C31H54O2 on the basis of mass spectrum
1H and 13C NMR
including DEPT experiment. The 1H NMR showed the pres-
ence of two doublet methyl signals at dH 0.80 and 0.86
(J= 6.7 Hz), six singlet methyl signals at dH 1.16, 0.99, 0.92,
0.87 (2CH3) and 0.75 in addition to a multiplet methine proton
at dH 2.94 and singlet methoxy protons at dH 3.26. The
13C
NMR spectrum and DEPT spectra showed the presence of
31 carbon signal for 31 carbons (CH3x8, –CH2x10, –CHx6, –
Cx6, –OCH3x1) suggesting a triterpenoidal skeleton. The
chemical shifts were found to be close to ﬁlicane triterpene nu-
cleus (Tsuzuki et al., 2001), with oxygen function(s) in ring A.
The doublet and singlet signals at dC 86.20 and 76.89, respec-
tively, were assigned for two oxygen-carrying carbons. Com-
paring the chemical shifts of these two carbons and other
neighboring carbons with those reported for the ﬁlicanes (Na-
kane et al., 2002; Tsuzuki et al., 2001), indicated that the oxy-
gen-bearing carbons must be located at C-3 and C-4 (ring A).
Also, by comparing the 13C NMR chemical shifts with those
reported for 3a-hydroxy,4-methoxy ﬁlicane (Tsuzuki et al.,croton oil-induced inﬂammation.
fter 6 h After 24 h After 30 h
1.0 ± 2.4 29.3 ± 2.2 28.0 ± 0.8
7.0 ± 1.0* 46.0 ± 1.8* 44.0 ± 1.1*
3.0 ± 1.3 59.0 ± 3.9 59.0 ± 4.1
Table 7 Hypoglycemic effect of total alcoholic extract on normal mice.
0 min 30 min 60 min 90 min 120 min 150 min
Gp. I 65.5 ± 0.5 78.5 ± 9.6 79.0 ± 7.6 82.5 ± 11.6 82.0 ± 2.0 72.0 ± 3.0
Gp. II 65.3 ± 3.5 90.0 ± 7.4 89.8 ± 7.6 75.7 ± 8.2 73.6 ± 7.0 71.1 ± 7.7
Gp. III 59.4 ± 5.6 52.5 ± 3.2 52.4 ± 3.4 49.2 ± 3.3
Gp. I: negative control; Gp. II: dose 400 mg; Gp. III: positive control (glipizide). These data represent the blood glucose level (mg/dl).
Table 8 Hypoglycemic effect of the alcoholic extract administered simultaneously and 30 min before glucose loading.
0 min 30 min 60 min 120 min 240 min
Gp. I 120.7 ± 10.4 310.3 ± 12.0 221.5 ± 17.3 151.5 ± 11.2 146.3 ± 9.7
Gp. II 127.0 ± 13.7 165.0 ± 19.4* 145.5 ± 10.9* 123.7 ± 10.6* 117.5 ± 10.1*
Gp. III 123.0 ± 8.8 120.9 ± 10.4* 121.4 ± 9.8* 131.7 ± 10.8* 137 ± 10.4
Gp. I: glucose load only; Gp. II: dose 600 mg; Gp. III: 600 mg extract fed 30 min before glucose loading. These data represent the blood glucose
level (mg/dl).
* P< 0.05.
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Figure 1 Structures of the isolated triterpenoids.
70 Z.Z. Ibraheim et al.2001), it seems that the methoxy group is located at C-3 since it
appears more downﬁeld (dC 86.20) while the hydroxyl group is
located at C-4 (dC 76.89) since it appears more upﬁeld. Gener-
ally, the substitution of hydroxyl group causes an upﬁeld shift
of both C-2 and C-4 and downﬁeld shift of C-3 (Brahmachari
and Chatterjee, 2002; Mahato and Kundu, 1994; Ngouamegne
et al., 2008). The upﬁeld shift of C-2 (at dC 25.19) in compound
3 relative to that reported for 3a-hydroxy,4-methoxy ﬁlicane
(Tsuzuki et al., 2001) (dC 30.54) conﬁrmed the position of
OCH3 to be at C-3. This suggestion was established by exten-
sive study of 2D NMR experiments [1H–1H COSY, HSQC and
HMBC]. The 1H–1H COSY showed the correlation of methine
proton at dH 2.94 with the CH2 protons at dH 1.18 (CH2-2).
The HSQC spectrum showed a correlation between themethine proton at dH 2.94 to the doublet carbon at dC 86.20,
suggesting the position of the methoxy group at C-3 and the
hydroxyl group at C-4. The HMBC spectrum revealed the cor-
relations of the methoxy group protons at dH 3.26 with C-3 (dC
86.20) and the methine proton at dH 2.94 with C-4, C-5 and C-
1, that established the OCH3 group at C-3 and the OH group
to be at C-4, the other HMBC correlations were shown in
Fig. 2. Finally the assignment of the structure was supported
by the EI-MS, which exhibited beside the molecular ion peak
at m/z 458 [M]+, other peaks at m/z 341, 217, 205 and 191 con-
ﬁrming that compound 3 is a ﬁlicane derivative with two oxy-
genated functional groups at ring A (Fig. 3). Based on these
evidences, the structure of compound 3 was deduced as 3a-
methoxy-4-hydroxyﬁlicane.
MeO
HO
OH
HO
Figure 2 Some HMBC correlation (ﬁ) of compounds 3 and 4 and NOESY correlation ( ) of compound 4.
H3CO
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+
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Figure 3 Some possible fragmentation pattern of compound 3.
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Figure 4 Structures of the isolated ﬂavonoids.
Phytochemical and biological studies of Adiantum capillus-veneris L. 71Compound 4: Occured as ﬁne needle crystals that gave po-
sitive color with Liebermann–Burchard’s test suggesting its
triterpenoidal nature. EI-MS gave a molecular ion peak at
m/z 444 [M]+ and its molecular formula was deduced from
EI-MS, 1H, 13C NMR including DEPT experiment to be
C30H52O2 indicating ﬁve degrees of unsaturation. IR spectrum
showed absorption bands attributed to hydroxyl group at 3465
and 2955 cm1 for C–H stretching. The 1H and 13C NMR data
of compound 4 (Tables 1 and 2) showed close resemblance
with those observed for compound 3 and 3a-hydroxy,4-meth-
oxy ﬁlicane (Tsuzuki et al., 2001) except for the signals of ring
A indicating that compound 4 is a ﬁlicane derivative. The 13C
NMR spectrum showed 30 signals for 30 carbons (8 CH3, 10
CH2, 6 CH and 6 –C–), the signals at dC 76.03 and 76.30 were
assigned for C-3 and C-4, respectively. The upﬁeld shift of C-3
(dC 76.03) and the downﬁeld shift of C-2 (dC 30.23) and the dis-
appearance of the methoxy signal in both 1H and 13C NMR
spectra comparing to those of compound 3 indicated the
replacement of OCH3 group by OH group. The assignment
of each carbon and its carrying proton was determined from
the HSQC while the identiﬁcation of each carbon and its
neighboring protons was established from HMBC spectrum
(Fig. 2, Table 2). From the previous data, compound 4 was de-
duced to be 3,4-dihydroxy ﬁlicane having an axial b-OH group
and an equatorial a-H at C-3 from the large coupling constant
of methine proton at dH 3.56 (dd, J= 7.0 and 13.9 Hz) (Li
et al., 2009; Wei et al., 2008) and this was supported from
the NOESY spectrum which showed NOE between the methylgroup (C-23) and H-3 (Fig. 2). Due to the presence of CH3-23
in b-conﬁguration in ﬁlicane triterpene, the OH group at C-4
must be present in a-conﬁguration. The establishment of the
structure was conﬁrmed by EI-MS (m/z 444 [M]+) which is less
than that of compound 3 by 14 mass units. The EI-MS spec-
trum exhibited besides the molecular ion peak at m/z 444
[M]+ other prominent peaks at m/z 429 [M-15], 426 [M-
H2O], 411 (MCH3H2O), 401, 341, 273, 205 and 191. Natu-
rally there is no evidence for the presence of 3,4-glycol, but it
may be derived form the corresponding epoxide (adiantoxide)
previously isolated from the plant (Berti et al., 1969; Nakane
et al., 2002). Based on these evidences, the structure of com-
pound 4 is 3-b,4-a-dihydroxy ﬁlicane (Fig. 1). This compound
was identiﬁed previously as one of the hydrolytic products of
adiantoxide (Berti et al., 1969); but this is the ﬁrst report for
its isolation from a natural source.
The physical characters and spectral data of compound 5
including 1H NMR and UV (experimental part and Table 3)
were found to be identical to those reported for quercetin. Fur-
ther conﬁrmation was carried out by co-chromatography
alongside authentic sample (Fig. 4).
Compound 6 gave positive tests for carbohydrates and/or
glycosides and ﬂavonoids (Mabry et al., 1970). The UV spec-
tral data with different ionizing and complexing reagents (Ta-
ble 3) indicated that this compound is a ﬂavonoid. The 1H
NMR (experimental part) showed the presence of ﬁve aro-
matic protons characteristic for quercetin pattern and an ano-
meric sugar proton that appears at dH 5.22 (1H, d, J= 7.6 Hz)
indicating its b-nature, the other sugar protons appear between
dH 3.1 and 4.0. The UV and
1H NMR of this compound are
similar to those reported for quercetin-3-O-b-D-glucoside
(Fathiazada et al., 2006). Mild acid hydrolysis showed that this
compound was hydrolyzed in one step that indicated that it
72 Z.Z. Ibraheim et al.contains one sugar moiety. Complete acid hydrolysis afforded
an aglycone identiﬁed as quercetin (m.p., m.m.p. and co-chro-
matography) and a sugar part identiﬁed as glucose (co-chro-
matography) using authentic sugars. So, compound 6 was
identiﬁed as quercetin-3-O-b-D-glucoside (Fig. 4).
Compound 7 gives positive tests for carbohydrates and/or
glycosides and ﬂavonoids (Mabry et al., 1970). The UV spec-
tral data with different ionizing and complexing reagents (Ta-
ble 3) indicated that this compound is a ﬂavonoid having free –
OH groups at C-5, C-7, C-30 and C-40. The 1H NMR data
(experimental part) showed a quercetin pattern and two ano-
meric sugar protons appear at dH 5.35 (1H, d, J= 7.4 Hz)
for glucose indicating its b-nature and at dH 5.12 (1H, d,
J= 1.9 Hz) together with the doublet methyl protons at dH
1.01 (3H, d, J= 6.1 Hz) for rhamnose indicating its a-nature.
Complete acid hydrolysis of compound 7 afforded an aglycone
identiﬁed as quercetin (m.p., m.m.p. and paper chromatogra-
phy [PC] using authentic sample) and sugars identiﬁed as glu-
cose and rhamnose [PC using butanol–acetic acid–water (4:1:5)
solvent system using authentic sugars]. From the above-men-
tioned data compound 7 was identiﬁed as rutin (Fig. 4).
The isolation of above-mentioned compounds from A.
capillus-veneris (Adiantaceae) is important from the chemotax-
onomic point of view, since the isolated compounds belong to
different natural groups previously isolated from other fern
families (Soeder, 1985).
4.2. Biological activity
4.2.1. Formalin induced inﬂammation
Using formalin induced inﬂammation, both of the total alco-
holic extract and its hexane fraction showed a signiﬁcant
anti-inﬂammatory activity. Usually, the pain and edema pro-
duced by formalin are mediated by substance P and bradyki-
nin in the early phase, followed by tissue mediated response
induced by histamine, 5HT, prostaglandins and bradykinins
(Wheeler-Aceto and Cowan, 1991). Thus, the anti-inﬂamma-
tory activity of the total extract and its hexane fraction may
be attributed to inhibition of one or some of these inﬂamma-
tory mediators (Nakazato and Takeo, 1998) where the total
extract contains ﬂavonoidal compounds that have anti-inﬂam-
matory activity (Bai and Zhu, 2010; Bai et al., 2010; Guardia
et al., 2001; Kazowska et al., 2010; Rogerio et al., 2010) and
in case of the n-hexane fraction that may be attributed to the
presence of sterols and triterpenes (Ding et al., 2010; Marino
et al., 1989; Micallef and Garg, 2009; Rı´os et al., 2000).
4.2.2. Croton oil-induced inﬂammation
The hexane fraction and compounds 3, 4 showed topical anti-
inﬂammatory activity after 6 h and continued for 30 h. The de-
layed topical anti-inﬂammatory activity may be due to the
poor absorption of these compounds from topical application
or may be due to the unsuitability of the formulation or the
used compounds may have mild effect to exert a clear action
(De Souza et al., 2009).
4.2.3. Hypoglycemic activity
4.2.3.1. Effect on normal mice. The alcoholic extract showed a
non-signiﬁcant effect using mice model. The started non-signif-
icant hyperglycemic effect and the non-signiﬁcant hypoglyce-
mic effects after 1.5 h may be due to the presence of sugarsor hyperglycemic agents, or may be the used dose is small to
exert a clear action.
4.2.3.2. Effect on glucose loaded rabbits. The OGTT using rab-
bit model showed a signiﬁcant hypoglycemic effect started
after 30 min for group II and continued for 4 hours; this effect
may be due to non-insulin mechanism. When the alcoholic ex-
tract was given 30 min before glucose loading, a signiﬁcant de-
crease in blood glucose level was observed after 30 min of
glucose loading which may be due to enhancing insulin secre-
tion from b-cells. The hypoglycemic effects of the alcoholic ex-
tract may be due to the presence of ﬂavonoids which are
known for their hypoglycemic and antioxidant effects (Kessler
et al., 2003; van Acker et al., 1996; Zhou et al., 2009). Further
investigations are warranted to identify the hypoglycemic
mechanism of the active principles.
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